19.900
−0,50%
2026-10-19
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -88.4% | +29.6% | 2 / 3 | -43.6% | -6.72 pp | -52.96 pp | +13.4% | 0.09 | 10.12 | 36,1 | −43,6% | 5,0 | −88,4% | 10.12 | 11.50 | −12,0% |
| Pts | 0 | 4 | 8 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 19.900 (close price on 2026-10-19)EPS (TTM): 1.967
Financial charts
1.Revenue & growth
VND bn36,1Q2/26
1.Revenue & growth
VND bn36,1Q2/26
2.Profit & growth
VND bn4,95Q2/26
3.Profit mix (Penman)
VND bn139Q2/26
4.Margins & cost structure
%45.8%Q2/26
5.Returns & cash cycle
% · days11.9%Q2/26
6.Earnings quality & cash
VND bn222Q2/26
7.Asset structure
VND bn1.089Q2/26
8.Funding & debt health
VND bn · times1.089Q2/26
9.Revenue backlog
VND bn2,33Q2/26
10.Valuation
times · %10,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %74Q2/26
Adjusted EPS growth, latest quarter
-88.4%
Average adjusted EPS growth, 3 quarters
29.6%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26